Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Post by diadon1945on Nov 28, 2012 12:28pm

210 Views

Post# 20655308

binary event

The PSP results are a binary event. Good results will offer a good gain. Bad results will bring the share price down to a nickle.Those who bought shares from 17-30 cents will sell most soon....and let the rest ride.

Bullboard Posts

The Market Online’s Weekly Cannabis Report – Nov. 15, 2024